[ad_1]
While Citi remains bullish on CrowdStrike shares, an analyst there conceded that a lot of the “hand-wringing” around the stock “has merit.”
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...